A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance

CCO Oncology Podcast

Contenido proporcionado por Clinical Care Options, LLC and Clinical Care Options. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Clinical Care Options, LLC and Clinical Care Options o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

9d ago 32:48

MP3•Episodio en casa

In this episode, listen to Matthew S. Davids, MD, MMSc, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for patients with CLL, including:

Contemporary treatment paradigms for patients with CLL
Safety and efficacy of current regimens
Molecular testing, including when and how to test for BTK inhibitor resistance
Considering BTK inhibitor resistance when sequencing therapy

Program faculty:

Matthew S. Davids, MD, MMSc
Associate Professor of Medicine
Harvard Medical School
Leader, Lymphoma Program
Dana-Farber/Harvard Cancer Center
Director of Clinical Research
Division of Lymphoma
Dana-Farber Cancer Institute
Boston, Massachusetts

Lindsey Roeker, MD
Assistant Attending
CLL Program Director
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Resources:
To review a CME-certified text activity and download slides associated with this podcast discussion, please visit the program page.

183 episodios

#Science #Fitness #Biology #Higher Education #Podcasting Education #Medicine #Clinical Care Options, LLC #Clinical Care Options #Essential Thrombocythemia #Myelofibrosis #Oncology #CME #Nonmalignant Hematological Disorders #Skin Cancer #Hematological Malignancies #Acute Myeloid Leukemia #Kidney Cancer #Melanoma #Gastrointestinal Cancer #Acute Lymphocytic Leukemia #Prostate Cancer #Myeloproliferative Neoplasms #Follicular Lymphoma #Glioblastoma #Nsclc #Multiple Myeloma #Hodgkin Lymphoma #Basal Cell Carcinoma #All #Polycythemia Vera #Breast Cancer #Dlbcl #Head And Neck Cancer #Liver Cancer #Sarcoma #Gastroesophageal Cancer #Lung Cancer #Hepatocellular Carcinoma #Urothelial Carcinoma #Cancer Screening #Renal Cell Carcinoma #AML #Ovarian Cancer #CPE #Lymphoma #Diffuse Large B-cell Lymphoma #Cll #Pancreatic Cancer #Beta-thalassemia #Chronic Myeloid Leukemia